Ulcerative colitis trials in New Zealand
1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleSafety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
- Where
- Auckland, Christchurch, Hamilton, Nelson, Upper Hutt
- Age
- 18 years to 75 years
- People
- 57 worldwide
- Run by
- Odyssey Therapeutics, Inc.
See details and how to joinNCT06850727